Qi An

发表

Efficient discovery of novel antimicrobials through integration of synthesis and testing in crude ribosome extract.

Yuanzheng Zhou, Tao Yang, Youfu Luo, 2019, Chemical communications.

Recent advances in Clp protease modulation to address virulence, resistance and persistence of MRSA infection.

Youfu Luo, Y. Ju, Yiwen Zhang, 2021, Drug discovery today.

Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1.

Youfu Luo, Qingxiang Sun, Da Jia, 2021, Journal of medicinal chemistry.

Engineering chromosome region maintenance 1 fragments that bind to nuclear export signals

Youfu Luo, Qingxiang Sun, Da Jia, 2019, Protein Science.

Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.

Tianyu Zhang, Yang Yang, Tao Yang, 2018, Bioorganic & medicinal chemistry letters.

Dihydrofolate reductase inhibitors for use as antimicrobial agents.

Tao Yang, Youfu Luo, Wenlian Qiao, 2020, European journal of medicinal chemistry.

Scaffold hopping of agomelatine leads to enhanced antidepressant effects by modulation of gut microbiota and host immune responses

A. Tong, Yang Yang, Youfu Luo, 2020, Pharmacology Biochemistry and Behavior.

Repurposed drug candidates for antituberculosis therapy.

Tao Yang, Youfu Luo, Yong Deng, 2020, European journal of medicinal chemistry.

A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).

A. Tong, Yang Yang, Tao Yang, 2019, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.

Lijuan Chen, Tianyu Zhang, Yang Yang, 2018, Bioorganic chemistry.